Abstract
The budding yeast, Saccharomyces cerevisiae, has been widely used in fermentation technology. In recent, yeast cell surface has been investigated as potential spaces for immobilizing molecules of interest. The technology of yeast cells to display foreign proteins or peptides by genetic manipulation has been called “cell surface engineering (arming technology)” or “molecular display technology.” Here, the yeast molecular display system is described as convenient method to produce an oral vaccine against various infectious diseases. An antigen derived from Candida albicans was successfully displayed, and it was evaluated on an effect in oral vaccination. Additionally, to expand a possibility of the yeast molecular display technology, screening approach on antigens using proteomic analyses is introduced. Useful combination of proteomic analysis and molecular display technology is discussed with practical application.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Adachi K, Kawana K, Yokoyama T et al (2010) Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus, (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7. Vaccine 28:2810–2817
Aoki W, Tatsukami Y, Kitahara N et al (2013) Elucidation of potentially virulent factors of Candida albicans during serum adaptation by using quantitative time-course proteomics. J Proteome 91:417–429
Arendrup MC (2013) Candida and candidaemia. Susceptibility and epidemiology. Dan Med J 60(11):B4698
Arendrup MC, Patterson TF (2017) Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis 216(suppl 3):S445–S451
Bassetti M, Peghin M, Timsit JF (2016) The current treatment landscape: candidiasis. J Antimicrob Chemother 71(suppl 2):ii13–ii22
Doerner A, Rhiel L, Zielonka S et al (2014) Therapeutic antibody engineering by high efficiency cell screening. FEBS Lett 588(2):278–287
Hara K, Shigemori T, Kuroda K et al (2012) Membrane-displayed somatostatin activates somatostatin receptor subtype-2 heterologously produced in Saccharomyces cerevisiae. AMB Express 2(1):63
Jeffery CJ (1999) Moonlighting proteins. Trends Biochem Sci 24(1):8–11
Kitahara N, Morisaka H, Aoki W et al (2015) Description of the interaction between Candida albicans and macrophages by mixed and quantitative proteome analysis without isolation. AMB Express 5:127
Laín A, Moragues MD, Ruiz JC et al (2007) Evaluation of a novel enzyme-linked immunosorbent assay to detect immunoglobulin G antibody to enolase for serodiagnosis of invasive candidiasis. Clin Vaccine Immunol 14(3):318–319
Lin Y, Shiraga S, Tsumuraya T et al (2004) Comparison of two forms of catalytic antibody displayed on yeast-cell surface. J Mol Catal B Enzym 28:241–246
Nakamura Y, Shibasaki S, Ueda M et al (2001) Development of novel whole-cell immunoadsorbents by yeast surface display of the IgG-binding domain. Appl Microbiol Biotechnol 57(4):500–505
Noble SM, Johnson AD (2007) Genetics of Candida albicans, a diploid human fungal pathogen. Annu Rev Genet 41:193–211
Rodríguez I, Chamorro R, Novoa B et al (2009) Beta-glucan administration enhances disease resistance and some innate immune responses in zebrafish (Danio rerio). Fish Shellfish Immunol 27:369–373
Shibasaki S, Ueda M (2009) Facing challenges for drug discovery using molecular display technology and combinatorial bioengineering. Yakugaku Zasshi 129:1333–1340
Shibasaki S, Ueda M (2010) Development of yeast molecular display systems focused on therapeutic proteins, enzymes, and foods: functional analysis of proteins and its application to bioconversion. Recent Pat Biotechnol 4(3):198–213
Shibasaki S, Ueda M (2014) Bioadsorption strategies with yeast molecular display technology. Biocontrol Sci 19(4):157–164
Shibasaki S, Ueda M (2016) Oral vaccine development by molecular display methods using microbial cells. Methods Mol Biol 1404:497–509
Shibasaki S, Ueda M (2017) Preparation of an oral vaccine by proteome analysis and molecular display technology. Methods Mol Biol 1625:237–245
Shibasaki S, Ueda M, Iizuka T et al (2001) Quantitative evaluation of the enhanced green fluorescent protein displayed on the cell surface of Saccharomyces cerevisiae by fluorometric and confocal laser scanning microscopic analyses. Appl Microbiol Biotechnol 55(4):471–475
Shibasaki S, Tanaka A, Ueda M (2003) Development of combinatorial bioengineering using yeast cell surface display-order-made design of cell and protein for bio-monitoring. Biosens Bioelectron 19(2):123–130
Shibasaki S, Kuroda K, Duc Nguyen H et al (2006) Detection of protein-protein interactions by a combination of a novel cytoplasmic membrane, targeting system of recombinant proteins and fluorescence resonance energy transfer. Appl Microbiol Biotechnol 70(4):451–457
Shibasaki S, Kawabata A, Ishii J et al (2007) Construction of a novel synergistic system for production and recovery of secreted recombinant proteins by the cell surface engineering. Appl Microbiol Biotechnol 75(4):821–828
Shibasaki S, Okada J, Nakayama Y et al (2008a) Isolation of bacteria which produce yeast cell wall-lytic enzymes and their characterization. Biocontrol Sci 13:91–96
Shibasaki S, Sakata K, Ishii J et al (2008b) Development of a yeast protein fragment complementation assay (PCA) system using dihydrofolate reductase (DHFR) with specific additives. Appl Microbiol Biotechnol 80:735–743
Shibasaki S, Maeda H, Ueda M (2009) Molecular display technology using yeast--arming technology. Anal Sci 25:41–49
Shibasaki S, Aoki W, Nomura T et al (2013) An oral vaccine against candidiasis generated by a yeast molecular display system. Pathog Dis 69(3):262–268
Shibasaki S, Aoki W, Nomura T et al (2014a) Evaluation of Mdh1 protein as an antigenic candidate for a vaccine against candidiasis. Biocontrol Sci 19(1):51–55
Shibasaki S, Karasaki M, Gräslund T et al (2014b) Inhibitory effects of H-Ras/Raf-1–binding affibody molecules on synovial cell function. AMB Express 4:82
Shibasaki S, Karasaki M, Ueda M (2014c) Combining proteomic strategies and molecular display technology for development of vaccines against Candida albicans. J Proteomics Bioinform 7(6):134–138
Shibasaki S, Karasaki M, Aburaya S et al (2016) A comparative proteomics study of a synovial cell line stimulated with TNF-α. FEBS Open Bio 6:418–424
Shigemori T, Kuroda K, Ueda M (2015) Screening of randomly mutagenized glucagon-like peptide-1 library by using an integrated yeast-mammalian assay system. J Biotechnol 209:96–101
Ståhl S, Gräslund T, Eriksson Karlström A et al (2017) Affibody molecules in biotechnological and medical applications. Trends Biotechnol 35(8):691–712
Tsuda K, Nishiya N, Umeyama T et al (2011) Identification of LY83583 as a specific inhibitor of Candida albicans MPS1 protein kinase. Biochem Biophys Res Commun 409(3):418–423
Ueda M (2016) Establishment of cell surface engineering and its development. Biosci Biotechnol Biochem 80(7):1243–1253
Xin H, Dziadek S, Bundle DR et al (2008) Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis. Proc Natl Acad Sci U S A 105(36):13526–13531
Yasui M, Shibasaki S, Kuroda K et al (2002) An arming yeast with the ability to entrap fluorescent 17beta-estradiol on the cell surface. Appl Microbiol Biotechnol 59(2–3):329–331
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Shibasaki, S., Karasaki, M., Aoki, W., Ueda, M. (2020). Prompt and Convenient Preparation of Oral Vaccines Using Yeast Cell Surface Display. In: Hesham, AL., Upadhyay, R., Sharma, G., Manoharachary, C., Gupta, V. (eds) Fungal Biotechnology and Bioengineering. Fungal Biology. Springer, Cham. https://doi.org/10.1007/978-3-030-41870-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-41870-0_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-41869-4
Online ISBN: 978-3-030-41870-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)